| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |